Marshall, G. M., Dalla Pozza, L., Hoogerbrugge, P. M., Kaspers, G. J. L., Bierings, M. B., van der Schoot, E., van Dongen, J., Law, T., Cross, S., Mueller, H., de Haas, V., Haber, M., Sutton, R., Révész, T., Alvaro, F., Suppiah, R., Norris, M. D., Pieters, R., Ng, A., de Groot-Kruseman, H. A., van der Velden, V. H., Venn, N. C., van den Berg, H., de Bont, E. S. J. M., Egeler, R. Maarten. Nature Publishing Group; 2013. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.

Liu, P. Y., Xu, N., Koach, J., Tee, A. E., Haber, M., Norris, M. D., Toon, C., Rooman, I., Xue, C., Cheung, B. B., Kumar, S., Marshall, G. M., Malyukova, A., Biankin, A. V., Liu, T., Scarlett, C. J., Sun, Y. T., Zhang, X. D., Ling, D., Su, S.-P., Nelson, C., Chang, D. K.. Nature Publishing Group; 2013. The histone deacetylase SIRT2 stabilizes Myc oncoproteins.